P. Chavanet

7.4k total citations
186 papers, 3.5k citations indexed

About

P. Chavanet is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, P. Chavanet has authored 186 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Infectious Diseases, 90 papers in Epidemiology and 30 papers in Pharmacology. Recurrent topics in P. Chavanet's work include Pneumonia and Respiratory Infections (39 papers), Antibiotics Pharmacokinetics and Efficacy (29 papers) and Antibiotic Resistance in Bacteria (24 papers). P. Chavanet is often cited by papers focused on Pneumonia and Respiratory Infections (39 papers), Antibiotics Pharmacokinetics and Efficacy (29 papers) and Antibiotic Resistance in Bacteria (24 papers). P. Chavanet collaborates with scholars based in France, United States and Mali. P. Chavanet's co-authors include H. Portier, Lionel Piroth, Michel Duong, Michèle Grappin, Marielle Buisson, Pierre‐Emmanuel Charles, Serge Aho, Denis Caillot, Frédéric Dalle and Delphine Croisier and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

P. Chavanet

178 papers receiving 3.3k citations

Peers

Countries citing papers authored by P. Chavanet

Since Specialization

Citations

This map shows the geographic impact of P. Chavanet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Chavanet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Chavanet more than expected).

Fields of papers citing papers by P. Chavanet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Chavanet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Chavanet. The network helps show where P. Chavanet may publish in the future.

Co-authorship network of co-authors of P. Chavanet

This figure shows the co-authorship network connecting the top 25 collaborators of P. Chavanet. A scholar is included among the top collaborators of P. Chavanet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Chavanet. P. Chavanet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Addition of daptomycin for the treatment of pneumococcal meningitis: protocol for the AddaMAP study 2023 ·BMJ Open ·P. Chavanet, Isabelle Fournel, Abderrahmane Bourredjem, Lionel Piroth, Mathieu Blot, (unknown), Christine Binquet	1
2	Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19? 2021 ·International Journal of Infectious Diseases ·(unknown), (unknown), Hervé Devilliers, (unknown), (unknown), (unknown), M. Buisson, P. Chavanet, MyLinh Duong, (unknown), Sophie Mahy, Arnaud Salmon‐Rousseau, (unknown), Mathieu Blot, Lionel Piroth	24
3	How should a positive PCR test result for COVID-19 in an asymptomatic individual be interpreted and managed? 2020 ·Médecine et Maladies Infectieuses ·(unknown), (unknown), P. Chavanet, Mathieu Blot, Lionel Piroth	11
4	Comparative review of imipenem/cilastatin versus meropenem 2020 ·Médecine et Maladies Infectieuses ·Arnaud Salmon‐Rousseau, (unknown), Mathieu Blot, M. Buisson, Sophie Mahy, P. Chavanet, Lionel Piroth	24
5	Benefits and Limits of Antiretroviral Drug Monitoring in Routine Practice 2019 ·Current HIV Research ·Thomas Maitre, Patrice Muret, Mathieu Blot, Anne Waldner, Michel Duong, (unknown), P. Chavanet, Serge Aho, Lionel Piroth	3
6	Prevalence and incidence of kidney diseases leading to hospital admission in people living with HIV in France: an observational nationwide study 2019 ·BMJ Open ·Magali Louis, Jonathan Cottenet, Arnaud Salmon‐Rousseau, Mathieu Blot, (unknown), Jean-Michel Rebibou, P. Chavanet, Christiane Mousson, Catherine Quantin, Lionel Piroth	6
7	Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis? 2017 ·Journal of Antimicrobial Chemotherapy ·Thomas Maitre, (unknown), Aurélie Chauffour, Christine Bernard, Najoua El Helali, Vincent Jarlier, Florence Reibel, P. Chavanet, Alexandra Aubry, Nicolas Véziris	25
8	A New Prognosis Score to Predict Mortality After Acute Pneumonia in Very Elderly Patients 2016 ·Journal of the American Medical Directors Association ·Alain Putot, (unknown), Sophie Perrin, Henri Bailly, Lionel Piroth, J.-F. Besancenot, Bernard Bonnotte, P. Chavanet, Pierre‐Emmanuel Charles, (unknown), Patrick Manckoundia	13
9	Corticosteroids in treating community-acquired pneumonia: has the time really come? 2016 ·Clinical Microbiology and Infection ·Mathieu Blot, Arnaud Salmon‐Rousseau, P. Chavanet, Lionel Piroth	3
10	Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study 2014 ·BMC Infectious Diseases ·Lionel Piroth, A. Péchinot, Vincent Di Martino, Yves Hansmann, Alain Putot, Isabelle Patry, Tahar Hadou, B. Jaulhac, Catherine Chirouze, Christian Rabaud, Alain Lozniewski, Catherine Neuwirth, P. Chavanet, Anne Minello	48
11	Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients 2013 ·BMC Infectious Diseases ·(unknown), Sophie Mahy, (unknown), Paul Ornetti, S. A. Ewing, Jean-Claude Guilland, Delphine Croisier, Laurence Duvillard, P. Chavanet, Jean-Françis Maillefert, Lionel Piroth	38
12	Pneumococcus infections: Is the burden still as heavy? 2012 ·Médecine et Maladies Infectieuses ·P. Chavanet	7
13	Factors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patients 2009 ·Clinical Microbiology and Infection ·B. Martha, Delphine Croisier, Annlyse Fanton, Karine Astruc, Lionel Piroth, Frédéric Huet, P. Chavanet	8
14	High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients 2008 ·Journal of Antimicrobial Chemotherapy ·D. Rey, Bruno Hoën, P. Chavanet, Marie‐Paule Schmitt, Guillaume Hoizey, (unknown), Gilles Peytavin, Bruno Spire, Clotilde Allavena, Myriam Diemer, T. May, J.L. Schmit, Michel Duong, Vincent Cálvez, Jean-Marie Lang	39
15	Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment. 2007 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Bruno Hoen, P. Chavanet, (unknown), (unknown), (unknown), Y Mouton, Yazdan Yazdanpanah	50
16	Candida spp. colonization significance in critically ill medical patients: a prospective study 2005 ·Intensive Care Medicine ·Pierre‐Emmanuel Charles, Frédéric Dalle, Hervé Aube, (unknown), Jean‐Pierre Quenot, Serge Aho, P. Chavanet, B Blettery	132
17	Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa 2005 ·Journal of Antimicrobial Chemotherapy ·(unknown), Didier Hocquet, Katy Jeannot, P. Chavanet, Patrick Plésiat	30
18	Experimental efficacy of combined ceftriaxone and amoxycillin on penicillin-resistant and broad-spectrum cephalosporin-resistant Streptococcus pneumoniae infection 1998 ·Journal of Antimicrobial Chemotherapy ·P. Chavanet	8
19	ACQUIRED IMMUNODEFICIENCY SYNDROME AFTER TRAVELLING IN AFRICA: AN EPIDEMIOLOGICAL STUDY IN SEVENTEEN CAUCASIAN PATIENTS 1987 ·The Lancet ·Daniel Vittecoq, R Roué, C Mayaud, (unknown), M. Armengaud, Brigitte Autran, T. May, M. Stern, P. Chavanet, (unknown), J Modaï, F.A. Rey, Jean‐Claude Chermann	28
20	Valeur comparée des réactions de fixation du complément et d'immunofluorescence indirecte pour le dépistage de la fièvre Q. 1984 ·P. Chavanet, A. Péchinot, (unknown), H. Portier	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact